David Clark, PhD, MSc

David Clark, PhD, MSc

Research Fellow, Computer-Aided Drug Design

David E. Clark began his career at Proteus Molecular Design, where he was involved in developing software for de novo ligand design and protein-ligand docking. He then worked in the CADD group of Aventis/Rhône-Poulenc Rorer before joining Argenta (acquired by Charles River in 2014) as a founding scientific member. Dr. Clark studied chemistry at the University of Oxford, then carried out his postgraduate studies at the Department of Information Studies at the University of Sheffield. In 2003, he was the recipient of the Corwin Hansch award, which is presented annually by the QSAR and Modelling Society.

LinkedIn Profile